RxDoctor Payments Data

Mickey Karram, MD

Urogynecology and Reconstructive Pelvic Surgery · West Chester, OHNPI 1245313535

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.7%), education and speaking fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Coloplast at 24.3% of the total. Reporting peaked in 2019 at $45,972 and has fallen 84.2% since, to $7,281 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$127,061in general payments, 2019–2025

Across 153 payments — averaging $830.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$31K
  • AbbVie$25K
  • Axonics, Inc.$22K
  • Contura, Inc.$15K
  • Surgalign Spine Technologies, Inc.$13K
  • Caldera Medical, Inc$7K
  • plus $13K from 14 others
$166,952in research payments, 2019–2025

Across 18 payments — averaging $9275.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coloplast$127K
  • AbbVie$19K
  • Cook Research Incorporated$10K
  • Ipsen Innovation$6K
  • Acell, Inc.$4K
  • Integra Lifesciences Corporation$300

What the payments were for

  • Consulting fees$58,02846%
  • Speaking & faculty fees$27,90522%
  • Travel & lodging$4,6874%
  • Food & beverage$7,6856%
  • Education$28,12722%
  • Entertainment$6290%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Coloplast30$30,914
AbbVie(2 entities)27$25,045
Axonics, Inc.53$22,234
Contura, Inc.4$15,193
Surgalign Spine Technologies, Inc.4$13,478
Caldera Medical, Inc5$7,117
Inspire Medical Systems, Inc.2$6,888
Urovant Sciences Inc5$3,690
RTI Surgical, Inc1$1,000
Boston Scientific6$438
Spinesmith Holdings, LLC2$426
Escala Medical Inc.1$168
Arthrex1$136
Hologic Sales And Service, LLC2$133
Medtronic3$110
Pfizer3$35
Coopersurgical, Inc.1$22
Astellas Pharma US Inc1$14
Renovia Inc1$11
Therapeuticsmd, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$127,061 in reported general payments places this provider in the 95th percentile of 60 urogynecology and reconstructive pelvic surgery providers in Ohio.

See all urogynecology and reconstructive pelvic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$91,454
Medicare patients
165
Services billed
474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol104$6,455
Ibuprofen13$86
Ondansetron Hcl12$35
Oxycodone Hcl13$26

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in West Chester

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →